Opportunity Information: Apply for RFA CA 24 031
The funding opportunity titled "Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required)" (Funding Opportunity Number RFA-CA-24-031) is a National Cancer Institute (NCI), National Institutes of Health (NIH) notice seeking applications to support the Statistics and Data Management Centers (SDMCs) that serve the NCI National Clinical Trials Network (NCTN). The award mechanism is a cooperative agreement (U10), which generally means the project will be carried out with substantial NIH/NCI involvement in key aspects of the work, consistent with the collaborative, network-based nature of national clinical trials infrastructure. The NOFO is positioned within the health and education activity category and is associated with CFDA numbers 93.394 and 93.395.
The core purpose of this opportunity is to maintain NCTN Network Group SDMCs that provide the statistical leadership and data management backbone for clinical trials run through the NCTN. In practical terms, the SDMCs are expected to supply the statistical expertise needed to design scientifically sound studies, monitor and analyze trial data appropriately, and ensure that data are collected, curated, and managed in a way that supports reliable conclusions and regulatory-quality reporting. These SDMCs are specifically intended to support clinical trials led by an associated NCTN Network Group Operations Center, indicating that applicants should be prepared to function as an integrated partner with the operations leadership for a network group rather than as a standalone data resource.
Because the announcement is labeled as a limited competition, it implies that eligibility may be constrained to a defined set of organizations or otherwise limited by NCI policy for this particular network infrastructure component, even though multiple applicant types are listed. Eligible applicants include a range of domestic organizations and governmental or quasi-governmental entities, including independent school districts, public housing authorities/Indian housing authorities, and Native American tribal organizations (other than federally recognized tribal governments), as well as other categories noted in the posting. The opportunity also explicitly includes certain additional eligible groups such as federal government agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions. At the same time, it clearly excludes non-domestic (non-U.S.) entities (foreign organizations) from applying, and it also excludes non-domestic components of U.S. organizations, reinforcing that the work and applicant organization must be U.S.-based.
Key administrative details provided include an original closing date of February 24, 2025, and a creation date of October 9, 2024. An award ceiling and expected number of awards are not specified in the provided source information, so prospective applicants would typically need to consult the full NOFO text for budget guidance, the number of anticipated SDMC awards, and any network-group-specific requirements. Overall, the opportunity is aimed at sustaining essential national clinical trials infrastructure by funding the statistical and data management centers that enable NCTN network groups to design, conduct, and manage high-quality cancer clinical trials at scale.Apply for RFA CA 24 031
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394, 93.395.
- This funding opportunity was created on 2024-10-09.
- Applicants must submit their applications by 2025-02-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Independent school districts, Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Previous opportunity: RESTORE Act Direct Component - Non-Construction Activities
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 24 031
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 24 031) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed) Apply for RFA CA 24 035 Funding Number: RFA CA 24 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: $850,000 |
| Single Source: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 24 034 Funding Number: RFA CA 24 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: $8,140,000 |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) Apply for PA 25 123 Funding Number: PA 25 123 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) Apply for PA 25 121 Funding Number: PA 25 121 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required) Apply for RFA CA 24 030 Funding Number: RFA CA 24 030 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) Apply for PAR 24 304 Funding Number: PAR 24 304 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed) Apply for RFA CA 24 033 Funding Number: RFA CA 24 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,700,000 |
| Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required) Apply for RFA CA 24 032 Funding Number: RFA CA 24 032 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) Apply for PAR 25 098 Funding Number: PAR 25 098 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) Apply for PAR 25 075 Funding Number: PAR 25 075 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) Apply for RFA DA 25 070 Funding Number: RFA DA 25 070 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) Apply for RFA DA 25 072 Funding Number: RFA DA 25 072 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) Apply for PAR 25 074 Funding Number: PAR 25 074 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) Apply for PAR 26 001 Funding Number: PAR 26 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Co-infection and Cancer (R01 Clinical Trial Not Allowed) Apply for PAR 25 082 Funding Number: PAR 25 082 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional) Apply for PAR 25 078 Funding Number: PAR 25 078 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) Apply for PAR 25 130 Funding Number: PAR 25 130 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed) Apply for RFA DA 25 068 Funding Number: RFA DA 25 068 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) Apply for PAR 25 131 Funding Number: PAR 25 131 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 069 Funding Number: RFA DA 25 069 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 24 031", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.